These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

658 related items for PubMed ID: 17284931

  • 1. Neuroprotective and intraocular pressure-lowering effects of (-)Delta9-tetrahydrocannabinol in a rat model of glaucoma.
    Crandall J, Matragoon S, Khalifa YM, Borlongan C, Tsai NT, Caldwell RB, Liou GI.
    Ophthalmic Res; 2007; 39(2):69-75. PubMed ID: 17284931
    [Abstract] [Full Text] [Related]

  • 2. Retinal ganglion cell neuroprotection in a rat model of glaucoma following brimonidine, latanoprost or combined treatments.
    Hernández M, Urcola JH, Vecino E.
    Exp Eye Res; 2008 May; 86(5):798-806. PubMed ID: 18394603
    [Abstract] [Full Text] [Related]

  • 3. Topically administered timolol and dorzolamide reduce intraocular pressure and protect retinal ganglion cells in a rat experimental glaucoma model.
    Seki M, Tanaka T, Matsuda H, Togano T, Hashimoto K, Ueda J, Fukuchi T, Abe H.
    Br J Ophthalmol; 2005 Apr; 89(4):504-7. PubMed ID: 15774933
    [Abstract] [Full Text] [Related]

  • 4. Ocular hypotensive effects of topically administered agmatine in a chronic ocular hypertensive rat model.
    Hong S, Kim CY, Lee WS, Shim J, Yeom HY, Seong GJ.
    Exp Eye Res; 2010 Jan; 90(1):97-103. PubMed ID: 19782071
    [Abstract] [Full Text] [Related]

  • 5. Three experimental glaucoma models in rats: comparison of the effects of intraocular pressure elevation on retinal ganglion cell size and death.
    Urcola JH, Hernández M, Vecino E.
    Exp Eye Res; 2006 Aug; 83(2):429-37. PubMed ID: 16682027
    [Abstract] [Full Text] [Related]

  • 6. Neuroprotective effects of angiotensin II type 1 receptor blocker in a rat model of chronic glaucoma.
    Yang H, Hirooka K, Fukuda K, Shiraga F.
    Invest Ophthalmol Vis Sci; 2009 Dec; 50(12):5800-4. PubMed ID: 19608537
    [Abstract] [Full Text] [Related]

  • 7. A rat model for acute rise in intraocular pressure: immune modulation as a therapeutic strategy.
    Ben Simon GJ, Bakalash S, Aloni E, Rosner M.
    Am J Ophthalmol; 2006 Jun; 141(6):1105-11. PubMed ID: 16765680
    [Abstract] [Full Text] [Related]

  • 8. Retinal damage after 3 to 4 months of elevated intraocular pressure in a rat glaucoma model.
    Mittag TW, Danias J, Pohorenec G, Yuan HM, Burakgazi E, Chalmers-Redman R, Podos SM, Tatton WG.
    Invest Ophthalmol Vis Sci; 2000 Oct; 41(11):3451-9. PubMed ID: 11006238
    [Abstract] [Full Text] [Related]

  • 9. Neuroprotective effects of Lycium barbarum Lynn on protecting retinal ganglion cells in an ocular hypertension model of glaucoma.
    Chan HC, Chang RC, Koon-Ching Ip A, Chiu K, Yuen WH, Zee SY, So KF.
    Exp Neurol; 2007 Jan; 203(1):269-73. PubMed ID: 17045262
    [Abstract] [Full Text] [Related]

  • 10. Induction of heat shock protein 72 protects retinal ganglion cells in a rat glaucoma model.
    Park KH, Cozier F, Ong OC, Caprioli J.
    Invest Ophthalmol Vis Sci; 2001 Jun; 42(7):1522-30. PubMed ID: 11381056
    [Abstract] [Full Text] [Related]

  • 11. Resistance of retinal ganglion cells to an increase in intraocular pressure is immune-dependent.
    Bakalash S, Kipnis J, Yoles E, Schwartz M.
    Invest Ophthalmol Vis Sci; 2002 Aug; 43(8):2648-53. PubMed ID: 12147598
    [Abstract] [Full Text] [Related]

  • 12. Neuroprotection by sodium channel blockade with phenytoin in an experimental model of glaucoma.
    Hains BC, Waxman SG.
    Invest Ophthalmol Vis Sci; 2005 Nov; 46(11):4164-9. PubMed ID: 16249495
    [Abstract] [Full Text] [Related]

  • 13. Intravitreal administration of erythropoietin and preservation of retinal ganglion cells in an experimental rat model of glaucoma.
    Tsai JC, Wu L, Worgul B, Forbes M, Cao J.
    Curr Eye Res; 2005 Nov; 30(11):1025-31. PubMed ID: 16282136
    [Abstract] [Full Text] [Related]

  • 14. Neuroprotection of retinal ganglion cells by brimonidine in rats with laser-induced chronic ocular hypertension.
    WoldeMussie E, Ruiz G, Wijono M, Wheeler LA.
    Invest Ophthalmol Vis Sci; 2001 Nov; 42(12):2849-55. PubMed ID: 11687528
    [Abstract] [Full Text] [Related]

  • 15. Detection of early neuron degeneration and accompanying microglial responses in the retina of a rat model of glaucoma.
    Naskar R, Wissing M, Thanos S.
    Invest Ophthalmol Vis Sci; 2002 Sep; 43(9):2962-8. PubMed ID: 12202516
    [Abstract] [Full Text] [Related]

  • 16. Intravitreal injections of GDNF-loaded biodegradable microspheres are neuroprotective in a rat model of glaucoma.
    Jiang C, Moore MJ, Zhang X, Klassen H, Langer R, Young M.
    Mol Vis; 2007 Sep 24; 13():1783-92. PubMed ID: 17960131
    [Abstract] [Full Text] [Related]

  • 17. JAK/STAT pathway mediates retinal ganglion cell survival after acute ocular hypertension but not under normal conditions.
    Huang Y, Cen LP, Choy KW, van Rooijen N, Wang N, Pang CP, Cui Q.
    Exp Eye Res; 2007 Nov 24; 85(5):684-95. PubMed ID: 17869246
    [Abstract] [Full Text] [Related]

  • 18. Optic nerve dynein motor protein distribution changes with intraocular pressure elevation in a rat model of glaucoma.
    Martin KR, Quigley HA, Valenta D, Kielczewski J, Pease ME.
    Exp Eye Res; 2006 Aug 24; 83(2):255-62. PubMed ID: 16546168
    [Abstract] [Full Text] [Related]

  • 19. Diabetes has an additive effect on neural apoptosis in rat retina with chronically elevated intraocular pressure.
    Kanamori A, Nakamura M, Mukuno H, Maeda H, Negi A.
    Curr Eye Res; 2004 Jan 24; 28(1):47-54. PubMed ID: 14704913
    [Abstract] [Full Text] [Related]

  • 20. Translimbal laser photocoagulation to the trabecular meshwork as a model of glaucoma in rats.
    Levkovitch-Verbin H, Quigley HA, Martin KR, Valenta D, Baumrind LA, Pease ME.
    Invest Ophthalmol Vis Sci; 2002 Feb 24; 43(2):402-10. PubMed ID: 11818384
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 33.